American Bio Medica Corporation (ABMC)

American Bio Medica Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Net Income	-1.41	-0.46	-0.8	-0.68	-1.03
Depreciation & Amortization	0.05	0.07	0.08	0.08	0.08
Share-Based Compensation	0.02	0	0	0.01	0
Other Operating Activities	0.58	-0.28	0.23	0.65	0.73
Operating Cash Flow	-0.77	-0.67	-0.48	0.06	-0.22
Capital Expenditures	0	0	-0	0	-0.02
Investing Cash Flow	0	0	-0	0	-0.02
Common Stock Issued	0	0.1	0.2	0	0.2
Other Financing Activities	0.69	0.59	0.38	-0.17	0.12
Financing Cash Flow	0.69	0.69	0.58	-0.17	0.32
Net Cash Flow	-0.08	0.02	0.09	-0.11	0.08
Free Cash Flow	-0.77	-0.67	-0.49	0.06	-0.24
Free Cash Flow Margin	-84.12%	-30.34%	-11.74%	1.59%	-6.25%
Free Cash Flow Per Share	-0.02	-0.02	-0.01	0.00	-0.01

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.